Cellular therapy using epitope-imprinted composite nanoparticles to remove -synuclein from an in vitro model

HIGHLIGHTS

• who: Mei-Hwa Lee et al. from the Department of Materials Science and Engineering, Shou University, Kaohsiung, Taiwan have published the article: Cellular Therapy Using Epitope-Imprinted Composite Nanoparticles to Remove -Synuclein from an In Vitro Model, in the Journal: Cells 2022, 11, 2584. of /2022/
• how: In this work one peptide (YVGSKTKEGVVHGVA) from SNCA was used as the epitope to construct magnetic molecularly imprinted composite nanoparticles (MMIPs).

SUMMARY

With regard to jurisdictional claims in Protein toxicity is thought to be implicated in many neurodegenerative diseases, including Alzheimer's disease, Parkinson . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.